Venous Thromboembolism

The researchers compared the efficacy of thromboprophylaxis with aspirin to low-molecular-weight heparin in patients with orthopedic trauma.

In this COVID-19 roundup, we discuss the expansion of eligible populations for a COVID-19 booster dose, approval of a nonprescription respiratory infection test, thrombosis risk after COVID-19 infections,...

Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after...

Researchers evaluated data on more than 50,800 participants with rheumatoid arthritis to determine the risk for venous thromboembolism with tofacitinib vs TNF inhibitors.

The American Society of Hematology has released new guidelines on the prevention, diagnosis, and management of venous thromboembolism.

The authors of the Childhood Cancer Survivor Study aimed to compare long-term venous thromboembolism risk among pediatric cancer survivors and their siblings.

The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.

Flu-like illness and inflammation are established risk factors for venous thromboembolism, but whether the influenza vaccine increases the risk for VTE is unknown.

Venous thromboembolism is one of the most common causes of death following bariatric surgery. However, the factors that raise the risk of venous thromboembolism in the 30 days post-surgery are not well...

The FDA has approved a new treatment option for the prophylaxis of venous thromboembolism in hospitalized patients.